Pale Fire Capital Se X4 Pharmaceuticals, Inc Transaction History
Pale Fire Capital Se
- $441 Billion
- Q4 2024
A detailed history of Pale Fire Capital Se transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Pale Fire Capital Se holds 1,401,964 shares of XFOR stock, worth $729,021. This represents 0.23% of its overall portfolio holdings.
Number of Shares
1,401,964
Previous 1,602,792
12.53%
Holding current value
$729,021
Previous $1.07 Billion
4.13%
% of portfolio
0.23%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding XFOR
# of Institutions
97Shares Held
99.6MCall Options Held
421KPut Options Held
80.6K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$8.8 Million3.52% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$7.79 Million0.82% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$5.55 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.2MShares$4.26 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY7.31MShares$3.8 Million2.9% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $35.7M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...